Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 1/22/2025YolTech to Initiate a Clinical Trial of FIC Bone Marrow-Targeted In V...
  • 1/21/2025NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
  • 1/21/2025CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...
  • 1/21/2025Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China
  • 1/21/2025NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...
  • 1/20/2025NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS
  • 1/20/2025NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...
  • 1/17/2025Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
  • 1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
  • 1/15/2025Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
  • 1/15/2025Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
  • 1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
  • 1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection
  • 1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
  • 1/13/2025Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
  • 1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
  • 1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
  • 1/12/2025WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
  • 1/11/2025Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...
  • 1/11/2025China Approves Combination Therapy of Padcev and Keytruda
  • 1/11/2025Merck's Gardasil 4 Receives New Indication Approval for Males in China
  • 1/11/2025U.S. FDA Granted Priority Review to Dizal's Sunvozertinib NDA
  • 1/6/2025GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment
  • 1/6/2025Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China
  • 12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
  • 12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC
  • Page:5/11 Total number of articles:316: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group